Protein & Cell

, Volume 4, Issue 4, pp 248–250

The newly emerged SARS-Like coronavirus HCoV-EMC also has an “Achilles’ heel”: current effective inhibitor targeting a 3C-like protease

  • Zhilin Ren
  • Liming Yan
  • Ning Zhang
  • Yu Guo
  • Cheng Yang
  • Zhiyong Lou
  • Zihe Rao
Perspective Protein & Cell

DOI: 10.1007/s13238-013-2841-3

Cite this article as:
Ren, Z., Yan, L., Zhang, N. et al. Protein Cell (2013) 4: 248. doi:10.1007/s13238-013-2841-3

Supplementary material

13238_2013_2841_MOESM1_ESM.pdf (269 kb)
Supplementary material, approximately 269 KB.

Copyright information

© Higher Education Press and Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Zhilin Ren
    • 1
    • 2
  • Liming Yan
    • 1
  • Ning Zhang
    • 4
  • Yu Guo
    • 2
  • Cheng Yang
    • 2
    • 4
  • Zhiyong Lou
    • 1
  • Zihe Rao
    • 1
    • 2
    • 3
    • 4
  1. 1.College of Pharmacy and State Key Laboratory of Medicinal Chemical BiologyNankai UniversityTianjinChina
  2. 2.Structural Biology Laboratory and MOE Laboratory of Protein Science, School of Medicine and Life ScienceTsinghua UniversityBeijingChina
  3. 3.National Laboratory of Macromolecules, Institute of BiophysicsChinese Academy of ScienceBeijingChina
  4. 4.Emerging Infection Disease Program, High-throughput Molecular Drug Discovery CenterTianjin Joint Academy of Biomedicine and TechnologyTianjinChina